Research

Care for the 15 most prevalent types of cancer in the U.S. cost approximately $156.2 billion in 2018, according to a team researchers.

The Orphan Drug Act (ODA) provides financial incentives to encourage the development of drugs for rare diseases or conditions for which treatments might not be developed otherwise.

This initiative involves collaborating with decision makers and developing policies to reduce prescription drug spending without stifling innovation in the pharmaceutical industry.

Overall, men had more than a year shaved off in 15 countries, compared to women in 11 countries.

This analysis is part of the USC-Brookings Schaeffer Initiative for Health Policy, which is a partnership between Economic Studies at Brookings and the University of Southern California Schaeffer Center for Health Policy & Economics.

This international, cross-sectional survey was developed by investigators from a range of clinical practice settings across low-income to high-income countries, including members of the WHO Essential Medicines Cancer Working Group.

Tezepelumab for Severe Asthma

This report makes the case that value-based pricing has the potential to better serve the American public by promoting research into drug products with greater clinical benefit that help meet the country’s health care needs.

The study, published in July, found that between 2009 and 2019, 74% of the 65 cancer drugs the group looked at increased in price faster than the rate of inflation.

President Biden has endorsed adding a hard cap on out-of-pocket Medicare Part D prescription drug spending.

The average cost of treating a COVID-19 patient who needs intensive care in Canada is estimated at more than $50,000, compared with $8,400 for someone who's had a heart attack.

Large savings are potentially available to commercial insurers from shifting cancer infusion care to nonhospital settings, but cost-sharing burdens could become very high for patients.

QALY as a measurement has received a lot of criticism. It's been criticized in concept or in the specifics of how it's defined or used.

Nearly one in four Americans reports difficulty affording their prescription medication, and system-wide costs for payers are rising as well.

Most Americans—79 percent—consider U.S. prescription drug prices to be unreasonable, with almost 3 in 10 reporting they go without prescribed medications because of cost.